Hun Ju Lee

Assistant Professor

  • 582 Citations
  • 12 h-Index
20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Mantle-Cell Lymphoma Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Peripheral T-Cell Lymphoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 582 Citations
  • 12 h-Index
  • 24 Article
  • 4 Letter
  • 2 Review article
  • 1 Comment/debate

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study

Strati, P., Fanale, M. A., Oki, Y., Turturro, F., Fayad, L. E., Bartlett, N. L., Gladstone, D. E., Kasamon, Y. L., Portlock, C. S., Wilson, W. H., Goy, A., Younes, A. & Lee, H. J., Feb 1 2019, In : Haematologica. 104, 2, p. e65-e67

Research output: Contribution to journalLetter

A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma

Lee, H. J., Badillo, M., Romaguera, J. & Wang, L., Feb 1 2019, In : British Journal of Haematology. 184, 3, p. 460-462 3 p.

Research output: Contribution to journalLetter

Mantle-Cell Lymphoma
carfilzomib
1 Citations
Mantle-Cell Lymphoma
Phase II Clinical Trials
Therapeutics
Survival
Myalgia

Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment

Romaguera, J. E., Lee, H. J., Tarapore, R., Prabhu, V., Allen, J., Schalop, L., Zloza, A., Ok, C. Y., Sadimin, E. T., Schenkel, J., Badillo, M. & Wang, L., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Therapeutics
TIC10 compound
PCI 32765